[Antenatal Steroid Therapy in Threatened Premature Birth - State of the Art]

Dimitra Stavropoulou1, Roland Hentschel1

  • 1Neonatologie und pädiatrische Intensivmedizin, Universitätsklinikum Freiburg, Freiburg.

Insights

This review summarizes recommendations for antenatal steroid therapy to induce lung maturation, focusing on special situations like chorioamnionitis and growth restriction. It analyzes benefits and risks of repetitive steroid use, based on the 2015 Cochrane analysis.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Premature birth remains a significant challenge in neonatal care.
  • Antenatal steroid therapy is crucial for lung maturation in preterm infants.
  • Specific maternal conditions complicate optimal timing and use of this therapy.

Purpose of the Study:

  • To review current literature on recommendations for antenatal steroid therapy.
  • To focus on its use in pregnancies complicated by chorioamnionitis, intrauterine growth retardation, and preeclampsia.
  • To clarify aspects of repetitive antenatal steroid administration and its implications.

Main Methods:

  • Literature review of current recommendations.
  • Analysis of the 2015 Cochrane review on antenatal steroid therapy.
  • Examination of data regarding maternal and neonatal outcomes.

Main Results:

  • Guidelines for antenatal steroid therapy in specific high-risk pregnancies are presented.
  • Advantages and disadvantages of repetitive steroid courses for mother and child are discussed.
  • Data on antenatal steroid therapy in multiple pregnancies are identified as insufficient.

Conclusions:

  • Antenatal steroid therapy is vital but requires careful consideration in complicated pregnancies.
  • Further research is needed on repetitive steroid administration and its use in multiple gestations.
  • Optimizing antenatal steroid therapy protocols can improve neonatal outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
984